A
IMNM icon

AlphaQuest’s Immunome IMNM Stock Holding History

AlphaQuest’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-48,968
Closed -$1.05M – 973
2025
Q4 		$1.05M Buy
48,968
+3,908
+9% +$68.6K 0.06% 425
2025
Q3 		$528K Sell
45,060
-6,079
-12% -$60.5K 0.03% 764
2025
Q2 		$476K Sell
51,139
-2,649
-5% -$21.7K 0.05% 619
2025
Q1 		$362K Buy
53,788
+45,920
+584% +$441K 0.04% 677
2024
Q4 		$83.6K Buy
7,868
+7,867
+786,700% +$95.1K 0.01% 1149
2024
Q3 		$15 Sell
1
-6,668
-100% -$94.7K ﹤0.01% 1856
2024
Q2 		$80.7K Buy
+6,669
New +$104K 0.01% 986

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

AlphaQuest's IMNM Position: Q1 2026 in Review

AlphaQuest sold out of Immunome (IMNM) in Q1 2026, closing a stake of 48,968 shares — an estimated $1.05M sold.

AlphaQuest first reported a position in IMNM in Q2 2024 and held it in 7 quarters. The position peaked at $1.05M in Q4 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • AlphaQuest reported no remaining Immunome position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 48,968 Immunome shares in Q1 2026, an estimated $1.05M.
  • AlphaQuest first reported a position in Immunome in Q2 2024 and held it in 7 quarters.
  • AlphaQuest's Immunome position peaked at $1.05M in Q4 2025.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.